title: Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus.
authors.forename: Chetan B
authors.initials: CB
authors.lastname: Narshi
authors.forename: Seema
authors.initials: S
authors.lastname: Haider
authors.forename: Charlotte M
authors.initials: CM
authors.lastname: Ford
authors.forename: David A
authors.initials: DA
authors.lastname: Isenberg
authors.forename: Ian P
authors.initials: IP
authors.lastname: Giles
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D003520:Cyclophosphamide